SHS has sold Spiegelberg to Luciole Medical AG
SHS and a minority co-shareholder have sold Spiegelberg GmbH to Luciole Medical AG.
Spiegelberg is a manufacturer of neuromonitoring and neurosurgical medical products. The company is known for its unique self-calibrating intra-cranial pressure monitors and its solid probes. The portfolio further includes disposables such as cerebrospinal fluid management catheters. The company was established more than 30 years ago in Hamburg, Germany, and is active in more than 40 countries.
Luciole Medical has established a first-mover position in brain monitoring by providing a complete solution to measure brain function parameters in a broad range of hospital settings, from surgeries and anesthesia to neurocritical care. Luciole Medical’s adhesive patch, intracranial probe and end-to-end analytics platform that can integrate information from additional sources, provide an array of tools to achieve unparalleled real-time data capture of cerebral oxygenation, an important predictor of brain function. It is the only company with a patch and a patented technology that can also measure the blood flow in the brain.
Since its foundation in 1993, SHS has been investing in innovative companies in the healthcare sector. With its investments, the firm helps shape European champions in their respective healthcare segments or support them in their further expansion. In addition to capital, SHS essentially supports its networks and expertise in the areas of approval and reimbursement in the USA and China, marketing and sales, staffing and exit planning.
Oaklins’ team in Germany acted as the exclusive sell-side M&A advisor in this transaction.
Talk to the deal team
Related deals
Jeco Energies has sold a significant minority interest to NPM Capital
NPM Capital has acquired a significant minority interest in Jeco Energies. By teaming up with NPM Capital, Jeco Energies is ready for the next step in its remarkable growth trajectory and strengthening its position as the leading industrial energy solutions provider.
Learn moreVivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.
NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth as well as investing in service quality, innovation and efficiency.
Learn moreGroupe JVS has completed an LBO with Capza and Bpifrance
The shareholders of Groupe JVS have completed an LBO with Capza and BpiFrance. Parquest sold their shares after partnering with the organization for three years. Groupe JVS’s management team will increase its ownership and remain as the majority shareholder of the group, alongside CAPZA and Bpifrance.
Learn more